{"result": {"id": "chatcmpl-221", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Retinal Neovascularization Community\",\n    \"summary\": \"This report analyzes the retinal neovascularization community, focusing on its key entities and their interrelationships. The community revolves around understanding and treating this condition, with a focus on research, treatment options, and patient care. Key entities include researchers, clinicians, pharmaceutical companies, and patients.  The community is driven by a shared goal of improving outcomes for those affected by retinal neovascularization.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"This community has significant impact due to the high prevalence of retinal neovascularization and its potential for severe visual impairment. The research and development efforts in this area are substantial, leading to a complex network of stakeholders with diverse interests.\",\n    \"findings\": [\n        {\n            \"summary\": \"Retinal Neovascularization: A Complex Condition\",\n            \"explanation\": \"Retinal neovascularization (RNV) is a condition where new blood vessels form in the retina. This can lead to vision loss and blindness. The causes of RNV are diverse, including age-related macular degeneration, diabetic retinopathy, and other genetic conditions. Understanding the underlying mechanisms of RNV is crucial for developing effective treatments.\",\n            \"references\": [\n                \"Retinal Neovascularization: A Complex Condition\", \n                \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549862/\"\n            ]\n        },\n        {\n            \"summary\": \"Research and Development Drive Progress\",\n            \"explanation\": \"The retinal neovascularization community is characterized by a strong focus on research and development.  This includes clinical trials, pre-clinical studies, and the development of new therapies. The goal is to improve treatment options for patients with RNV and prevent vision loss.\",\n            \"references\": [\n                \"Research and Development Drive Progress\", \n                \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549862/\"\n            ]\n        },\n        {\n            \"summary\": \"Treatment Options: A Multifaceted Approach\",\n            \"explanation\": \"Treating RNV requires a multifaceted approach, often involving a combination of therapies. These include laser photocoagulation, cryotherapy, and anti-VEGF drugs. The choice of treatment depends on the severity of the condition, individual patient factors, and other considerations.\",\n            \"references\": [\n                \"Treatment Options: A Multifaceted Approach\", \n                \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549862/\"\n            ]\n        },\n        {\n            \"summary\": \"Pharmaceutical Companies Play a Vital Role\",\n            \"explanation\": \"Pharmaceutical companies are key players in the retinal neovascularization community, developing and marketing new drugs for treating this condition. These companies invest heavily in research and development to create innovative therapies that can improve patient outcomes.\",\n            \"references\": [\n                \"Pharmaceutical Companies Play a Vital Role\", \n                \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549862/\"\n            ]\n        },\n        {\n            \"summary\": \"Patient Advocacy and Support Groups\",\n            \"explanation\": \"Patients with RNV often rely on patient advocacy groups and support networks for information, resources, and emotional support. These organizations provide valuable services to patients and their families, helping them navigate the challenges of living with this condition.\",\n            \"references\": [\n                \"Patient Advocacy and Support Groups\", \n                \"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549862/\"\n            ]\n        }\n    ]\n}\n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743089359, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 802, "prompt_tokens": 2048, "total_tokens": 2850, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n64,RETINAL,\"The **retinal** is a part of the eye. It is a crucial component of the eye, specifically studied for its role in vision.  It is also important for understanding how Erianin affects the eye. The retinal tissue is essential for studying vision and has been a focus of research, particularly in the rabbit model. \n\",5\n2252,ANXA1,\"The **ANXA1** protein is a key player in inflammation and cell signaling. It participates in the ANXA1/FPR2/SHP2/NLRP3 inflammasome/pyroptosis axis, modulating inflammatory processes.  Furthermore, ANXA1 can inhibit NLRP3 inflammasome activation, suggesting its role in regulating immune responses. Notably, it also exhibits anti-inflammatory properties, highlighting its complex and multifaceted function within the cellular environment. \n\",8\n4228,PRO-ANGIOGENIC CYTOKINES,,1\n4229,PRO-INFLAMMATORY CYTOKINES,,1\n4230,AORTIC OUTGROWTH,,1\n4232,NEURONAL PROTECTIVE FUNCTION,,1\n70,CRA,\"The **CRA** (Central Region of the American) is a feeding vessel for 5 (23%) eyes. \n\",1\n71,EYE,\"The **eye** is a part of the body and the organ of vision. It is responsible for allowing us to see our surroundings.  Specifically, the eye where the CNV (Choroidal Neovascularization) was detected is mentioned in the provided descriptions. \n\",7\n73,ARTREIOLE,,1\n1090,BORIC ACID,Borac Acid is a chemical compound,6\n1094,OXIDATIVE DAMAGE,,2\n340,PATIENT,\"The **patient** is an individual receiving anti-VEGF therapy, who may have undergone a kidney transplant.  They are also participants in a study or the subject of treatment for various conditions such as brain edema and a mass effect, metastatic cutaneous melanoma, and other medical treatments. \n\n\nLet me know if you'd like to explore any specific aspect of this summary further! \n\",7\n3083,KIDNEY TRANSPLANT,\"A **kidney transplant patient** has a history of kidney transplantation, meaning they have received a new kidney from a donor. \n\",1\n4204,INFLAMMATORY CHORODIAL NEOVASCULARIZATION,A condition that causes inflammation in the choroid,2\n1208,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR,\"The **anti-vascular endothelial growth factor (VEGF)** drug is used to treat both **MNV** and **retinal conditions**. \n\",6\n2675,INTRAVITREAL,\"**INTRAVITREAL** injections are administered into the **eye**. This location is commonly used for both **Aflibercept** and other anti-VEGF medications. \n\",2\n5313,SYPHILITIC CHORIORETINITIS,A condition of the eye caused by syphilis,1\n5314,PREDNISOLONE,,1\n1091,ATF4,A protein that activates transcription,1\n1983,RNV,\"The **RNV** study subject was a condition called **Retinal Vascular Necrosis (RNV)**.  This refers to the process of retinal neovascularization, which is the formation of new blood vessels in the retina. \n\",4\n2200,PI3K/AKT SIGNALING PATHWAY,,3\n4849,ASTHMATIC,Group of mice with asthma,2\n4913,GPNTS,A co-assembled glycopeptide nanotransforrs,3\n4914,MRP@DOX,\"The **MRP@DOX** drug delivery system is a potential treatment strategy for fundus diseases. It utilizes a drug that targets M2 macrophages within the fundus, aiming to address various conditions affecting this area of the eye. \n\",4\n1093,CORNEAL NEOVASCULARIZATION,\"**Corneal neovascularization** is a serious change in the cornea caused by various factors, leading to abnormal blood vessel growth. This condition can be a severe complication of corneal diseases and is studied in experiments.  It involves the formation of new blood vessels on the cornea, which can cause significant changes to its structure and function.  Corneal neovascularization is a process that occurs within the eye. \n\",4\n1910,INFLAMMATORY CYTOKINES,\"Inflammatory cytokines are a group of molecules that play a crucial role in the inflammatory process. These chemicals act as triggers, initiating a cascade of events within the body that ultimately lead to inflammation. \n\",2\n1172,RETINAL NEOVASCULARIZATION,\"**Retinal neovascularization** (also known as **neovascular retinopathy**) is a condition characterized by abnormal blood vessel growth in the retina. This pathological process can be associated with neurodegeneration and ocular diseases, leading to serious vision-threatening complications.  It's often studied in diagnostic accuracy studies and classified as an eye condition. The process of new blood vessel formation in the retina (neovascularization) is inhibited by a protein called Opticin. \n\",4\n2199,ANNEXIN A2,Protein involved in retinal neovascularization,2\n4915,DOXORUBICIN (DOX),An anti-cancer drug,2\n4919,DRUG DELIVERY SYSTEM,,4\n4949,MONOLITH/HYDROGEL COMPOSITE,A composite material used as a carrier for TA,2\n5401,INNER LIMITING MEMBRANE,Membrane separating the inner part of the eye from the rest of the eye,1\n1169,MIR-299-3P,MicroRNA involved in regulating gene expression,1\n1908,CHEMICAL INJURY,A type of injury to the eye caused by chemicals,4\n1403,CORNEA,\"The **cornea** is the transparent outer layer of the eye. It is a crucial part of the eye, studied for its role in vision and affected by chemical injuries.  It is also known as the tissue of the eye and is essential for focusing light onto the retina. \n\",1\n1909,NEOCORNEA,Part of the eye that is affected by chemical injuries,1\n2055,HGSNAT,Gene responsible for retinitis pigmentosa,2\n2056,RETINITIS PIGMENTATOS,\"Retinitis pigmentosa (RP) is a type of eye disease that can be caused by a genetic condition.  It is often associated with the development of retinitis pigmentosa, which is characterized by the degeneration of photoreceptor cells in the retina. \n\",3\n2098,VITREOUS,\"The **vitreous** is a clear, gel-like substance found in the eye. \n\",1\n2201,ANXA2,\"The **ANXA2** protein plays a role in neovascularization, which is the formation of new blood vessels. It also promotes the development of retinal neovascularization (RNV), a condition that can lead to vision loss. \n\",3\n2046,HRECS,\"The **HRECS** refers to both **human embryonic retinal cells** and **human retinal endothelial cells**.  These are types of cells found in the retina, a crucial part of the eye responsible for vision. Human embryonic retinal cells originate from an early stage embryo, while human retinal endothelial cells are specialized cells that line blood vessels within the retina. \n\",2\n2868,CASE,,1\n4205,65,\"Number of eyes included in the study\nNumber of patients in the study\",3\n4917,LEGUM,,1\n59,MACULA,\"The **macula** is a crucial area of the retina, located in the central part of the eye. It plays a vital role in sharp vision and color perception.  Specifically, it's responsible for central vision and is affected by Ocular von Hippel-Lindau disease. The macula is considered a \"\"part of the eye\"\" and a \"\"part of the retina.\"\" \n\",3\n60,CILIORETINAL ARTERY,A blood vessel in the eye that supplies the macula,1\n2057,CYSTOID MACULAR EDEMA,\"Cystoid macular edema (CME) is an eye condition characterized by fluid buildup in the macula, a central part of the retina responsible for sharp vision.  It can cause blurry or distorted vision and affect central vision. \n\",1\n4916,NANO-SIZE,,1\n2058,IN SILICO ANALYSIS,,1\n2376,CHOROIDAL,\"The **choroidal** tissue is a part of the eye. It is located behind the retina and is involved in nutrient supply to the retina, as well as in the regulation of light passing through the eye.  It can be affected by MNV (measles virus) infection. \n\",1\n4918,CANCER DRUG,,1\n4948,TRIAMCINOLONE ACETONIDE (TA),Anti-inflammatory drug used in treating corneal neovascularization,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n993,RETINAL,ANGIOGENESIS,Retinal angiogenesis is a critical process for normal retinal function,143\n1831,ANXA1,RETINA,\"ANXA1 is induced in the retina after OIR injury\nANXA1 expression increased in the retina after OIR injury\",16\n1832,ANXA1,PRO-ANGIOGENIC CYTOKINES,ANXA1 deficiency increases pro-angiogenic cytokines,9\n1833,ANXA1,PRO-INFLAMMATORY CYTOKINES,\"The **ANXA1** protein plays a complex role in the immune response.  Specifically, ANXA1 deficiency has been shown to increase levels of **pro-inflammatory cytokines**, suggesting a potential link between ANXA1 and inflammatory processes. However, research also indicates that ANXA1 can inhibit the activity of these pro-inflammatory cytokines and promote reparative angiogenesis, indicating a more nuanced role in regulating inflammation and tissue repair. \n\",9\n1838,ANXA1,AORTIC OUTGROWTH,ANXA1 inhibits aortic outgrowth and promotes pathological NV to exacerbate retinal dysfunction after ischemia injury,9\n1839,ANXA1,NEURONAL PROTECTIVE FUNCTION,ANXA1 exhibits neuronal protective function in ischemic retinopathy,9\n32,CRA,EYE,\"The CRA supplied the eye with blood vessels\nThe CRA is a feeding vessel for the eye\",8\n33,EYE,ARTREIOLE,The eye has arterioles that supply it with blood,8\n347,BORIC ACID,OXIDATIVE DAMAGE,\"Boric acid may reduce oxidative damage in the eye\nBoric acid may reduce oxidative damage in the cornea\",8\n1262,PATIENT,KIDNEY TRANSPLANT,The patient is the subject of a kidney transplant event,8\n1811,INFLAMMATORY CHORODIAL NEOVASCULARIZATION,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR,\"Study participants were treated with anti-VEGF injections for inflammatory CNV\nAnti-VEGF is used to treat inflammatory CNV\",8\n1813,ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR,INTRAVITREAL,Anti-VEGF injections are administered intravitreally,8\n2390,SYPHILITIC CHORIORETINITIS,PATIENT,The patient is suffering from syphilitic chorioretinitis,8\n2392,PATIENT,PREDNISOLONE,Prednisolone is a medication prescribed for the patient,8\n343,BORIC ACID,ATF4,\"Boric acid activates ATF4, which regulates antioxidant status in the eye\",7\n818,RNV,PI3K/AKT SIGNALING PATHWAY,Low activity of PI3K/AKT signaling pathway could attenuate the role of ANXA2,7\n2123,RETINAL,ASTHMATIC,Asthmatic mice showed more CNV and vascular leakage in the retina compared to control mice,7\n2164,GPNTS,MRP@DOX,The GPNTs are a part of the MRP@DOX drug delivery system,7\n349,CORNEAL NEOVASCULARIZATION,OXIDATIVE DAMAGE,\"Corneal neovascularization is associated with oxidative damage\nOxidative damage can lead to corneal neovascularization\",6\n675,INFLAMMATORY CYTOKINES,CORNEAL NEOVASCULARIZATION,\"Inflammation can cause new blood vessel formation in the cornea, leading to CNV\",6\n812,RETINAL NEOVASCULARIZATION,ANNEXIN A2,\"ANXA2 promotes the development of RNV\nANXA2 is involved in the development of RNV\",6\n2167,MRP@DOX,DOXORUBICIN (DOX),The MRP@DOX nanoparticles deliver Doxorubicin (DOX) as a drug,6\n2184,DRUG DELIVERY SYSTEM,MONOLITH/HYDROGEL COMPOSITE,The composite serves as a carrier for TA,6\n2449,RETINAL,INNER LIMITING MEMBRANE,The inner limiting membrane is part of the retina,6\n376,MIR-299-3P,RETINAL NEOVASCULARIZATION,miR-299-3p regulates retinal neovascularization,5\n671,CHEMICAL INJURY,CORNEA,\"Inflammation via promoting angiogenesis factor is associated with corneal injury\nChemical injuries can affect the cornea\",5\n672,CHEMICAL INJURY,NEOCORNEA,\"Chemical injuries can lead to necrosis of the anterior segment of the eye\nNecrosis of the anterior segment of the eye is a result of chemical injuries\",5\n745,HGSNAT,RETINITIS PIGMENTATOS,The gene HGSNAT is associated with retinitis pigmentosa,5\n762,VITREOUS,RETINAL NEOVASCULARIZATION,Vitreous is a component of the eye that can contribute to retinal neovascularization,5\n813,ANNEXIN A2,PI3K/AKT SIGNALING PATHWAY,ANXA2 can promote PI3K/AKT signaling pathway,5\n815,ANXA2,HRECS,ANXA2 expression is positively related with RNV-forming ability of HRECs in vitro,5\n1126,RNV,CASE,Case of RNV is likely responsive to anti-vascular endothelial growth factor and may be removed surgically,5\n1812,INFLAMMATORY CHORODIAL NEOVASCULARIZATION,65,\"Study participants were 65 patients with inflammatory CNV\nStudy participants had 65 eyes treated with anti-VEGF injections\",5\n1815,INTRAVITREAL,65,Study participants had 65 eyes treated with anti-VEGF injections,5\n2168,MRP@DOX,LEGUM,The MRP@DOX nanoparticles can be induced transformation by legum,5\n31,MACULA,CILIORETINAL ARTERY,The cilioretinal artery supplies the macula,4\n747,RETINITIS PIGMENTATOS,CYSTOID MACULAR EDEMA,Cystoid macular edema is a condition that can be caused by retinitis pigmentosa,4\n2165,GPNTS,NANO-SIZE,The GPNTs are nano-sized and can be induced transformation by legum,4\n746,HGSNAT,IN SILICO ANALYSIS,\"PolyPhen-2, SIFT, and MutationTaster were used to analyze the mutations in HGSNAT\",3\n2124,CHOROIDAL,ASTHMATIC,Asthmatic mice showed more CNV and vascular leakage in the choroid compared to control mice,3\n2170,DOXORUBICIN (DOX),CANCER DRUG,A type of anti-cancer drug,3\n2185,TRIAMCINOLONE ACETONIDE (TA),MONOLITH/HYDROGEL COMPOSITE,TA is the active ingredient in the monolith/hydrogel composite,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_8cd09a0b3cb740ec1cba8ddd3d6a5e85f6887c1758474741fb9af1a1bbbf2056_v2"}